Marassi, V.; Zanoni, I.; Ortelli, S.; Giordani, S.; Reschiglian, P.; Roda, B.; Zattoni, A.; Ravagli, C.; Cappiello, L.; Baldi, G.;
et al. Native Study of the Behaviour of Magnetite Nanoparticles for Hyperthermia Treatment during the Initial Moments of Intravenous Administration. Pharmaceutics 2022, 14, 2810.
https://doi.org/10.3390/pharmaceutics14122810
AMA Style
Marassi V, Zanoni I, Ortelli S, Giordani S, Reschiglian P, Roda B, Zattoni A, Ravagli C, Cappiello L, Baldi G,
et al. Native Study of the Behaviour of Magnetite Nanoparticles for Hyperthermia Treatment during the Initial Moments of Intravenous Administration. Pharmaceutics. 2022; 14(12):2810.
https://doi.org/10.3390/pharmaceutics14122810
Chicago/Turabian Style
Marassi, Valentina, Ilaria Zanoni, Simona Ortelli, Stefano Giordani, Pierluigi Reschiglian, Barbara Roda, Andrea Zattoni, Costanza Ravagli, Laura Cappiello, Giovanni Baldi,
and et al. 2022. "Native Study of the Behaviour of Magnetite Nanoparticles for Hyperthermia Treatment during the Initial Moments of Intravenous Administration" Pharmaceutics 14, no. 12: 2810.
https://doi.org/10.3390/pharmaceutics14122810
APA Style
Marassi, V., Zanoni, I., Ortelli, S., Giordani, S., Reschiglian, P., Roda, B., Zattoni, A., Ravagli, C., Cappiello, L., Baldi, G., Costa, A. L., & Blosi, M.
(2022). Native Study of the Behaviour of Magnetite Nanoparticles for Hyperthermia Treatment during the Initial Moments of Intravenous Administration. Pharmaceutics, 14(12), 2810.
https://doi.org/10.3390/pharmaceutics14122810